Actively Recruiting

Phase 4
Age: 40Years - 70Years
All Genders
NCT07225348

Treatment of Perioral Wrinkles Using Topical Poly-L-lactic Acid and Microneedling Device

Led by Skincare Physicians of Chestnut Hill · Updated on 2025-12-05

26

Participants Needed

1

Research Sites

46 weeks

Total Duration

On this page

Sponsors

S

Skincare Physicians of Chestnut Hill

Lead Sponsor

G

Galderma R&D

Collaborating Sponsor

AI-Summary

What this Trial Is About

The first goal of this clinical trial is to learn if topical application of PLLA in conjunction with a microneedling treatment works to treat perioral wrinkles in adults. The second goal is to see whether the application of topical PLLA is more effective before or after a microneedling treatment. The main questions it aims to answer are: * Is PLLA present within the MN channels from in vivo biopsy samples? * Is it safe to combine topical PLLA and MN in the treatment of perioral wrinkles, as determined by the incidence and severity of adverse events in healthy subjects? * Does overall aesthetic and skin texture improve in combining microneedling with topical PLLA in the treatment of mild to moderate perioral wrinkles? * Is it the treatment of topical PLLA more effective when applied before or after a microneedling treatment. Researchers will compare the application of PLLA before a microneedling treatment to a microneedling treatment with PLLA application after to see which treatment method is more effective. Participants will: \- receive 2 treatments spaced 4-6 weeks apart of topical PLLA and microneedling

CONDITIONS

Official Title

Treatment of Perioral Wrinkles Using Topical Poly-L-lactic Acid and Microneedling Device

Who Can Participate

Age: 40Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Males and non-pregnant, non-lactating females aged 40 to 70 years
  • Fitzpatrick Skin Type I-IV
  • Wrinkle severity graded 1-3 on Lemperle scale by investigator
  • Able to provide written informed consent and comply with study procedures and follow-up visits
  • Signed informed consent obtained before any study-specific procedure
Not Eligible

You will not qualify if you...

  • Lesions suspicious for malignancy, actinic keratosis, melasma, vitiligo, cutaneous papules/nodules, or active inflammatory lesions in treatment area
  • Tenderness in treatment area
  • History of keloid formation or hypertrophic scarring
  • History of trauma or surgery to treatment area
  • Scar present in areas to be treated
  • Silicone or synthetic material injections in treatment areas
  • Injection of fat, collagen, hyaluronic acid, or dermal fillers within previous 12 months
  • Dermabrasion or laser treatment in treatment areas within previous 12 months
  • Botulinum toxin injections in treatment areas within prior 6 months
  • Active smokers (0.5 pack/day) or quit within 3 months prior to treatment
  • Active, chronic, or recurrent infection
  • History of compromised immune system or current immunosuppressive treatment
  • Sensitivity to analgesic agents, Aquaphor, topical or local anesthetics
  • Excessive sun exposure or tanning bed use within 30 days prior to treatment
  • Treatment with fish oil within 14 days prior to treatment
  • Treatment with aspirin or blood thinners within 14 days prior to treatment
  • History or presence of significant bleeding disorder
  • Co-morbid condition limiting participation or follow-up compliance
  • History of drug or alcohol abuse
  • Any issue interfering with safety, efficacy assessment, or ability to consent
  • Treatment with investigational device or agent within 30 days before or during study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

SkinCare Physicians

Chestnut Hill, Massachusetts, United States, 02467

Actively Recruiting

Loading map...

Research Team

J

Jessica G Labadie, MD

CONTACT

J

Joaninha Barbosa, BS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here